TransMedics Group (TMDX) PT Lowered to $90 at Piper Sandler, Reflecting Revised Outlook
Tweet Send to a Friend
Piper Sandler analyst Matt O\'Brien lowered the price target on TransMedics Group (NASDAQ: TMDX) to $90.00 (from $110.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
